Literature DB >> 33479686

Leishmania infantum isolates exhibit high infectivity and reduced susceptibility to amphotericin B.

Paula Faral-Tello1, Gonzalo Greif1, Dinora Satragno2, Yester Basmadjián3, Carlos Robello1,4.   

Abstract

Leishmaniasis is a neglected disease caused by a protozoan parasite of the Leishmania species in over 98 countries in five continents. Visceral leishmaniasis is one of the main forms of the disease and is mainly caused by Leishmania infantum, whose main vector is the dipteran Lutzomyia longipalpis. The presence of the vector in Uruguay was recorded for the first time in 2010 and an autochthonous outbreak of canine visceral leishmaniasis occurred in the northern locality of the country in 2015. We report the isolation in blood-free FBS-supplemented defined media of five isolates responsible for the referred outbreak, and characterize them in terms of their growth as promastigotes, infectivity and replication in human derived monocytes and drug resistance. Results indicate similar promastigote growth among the strains, enhanced infectivity and replication for the five strains isolated from the Uruguayan outbreak when compared with reference strains from South America, equivalent drug susceptibility for miltefosine and nifurtimox and a significant difference in IC50 values for amphotericin B between the Uruguayan strains, 3-4 fold higher than the reference strain. This journal is © The Royal Society of Chemistry 2020.

Entities:  

Year:  2020        PMID: 33479686      PMCID: PMC7651856          DOI: 10.1039/d0md00073f

Source DB:  PubMed          Journal:  RSC Med Chem        ISSN: 2632-8682


  22 in total

1.  IDENTIFICATION OF CANINE VISCERAL LEISHMANIASIS IN A PREVIOUSLY UNAFFECTED AREA BY CONVENTIONAL DIAGNOSTIC TECHNIQUES AND CELL-BLOCK FIXATION.

Authors:  Tuanne Rotti Abrantes; Maria de Fátima Madeira; Denise Amaro da Silva; Carolina dos Santos F S Perié; Artur Augusto V Mendes Júnior; Rodrigo Caldas Menezes; Valmir Laurentino Silva; Fabiano Borges Figueiredo
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-02-23       Impact factor: 1.846

2.  First visceral leishmaniasis focus in Argentina.

Authors:  Od Salomon; A Sinagra; Mc Nevot; G Barberian; P Paulin; Jo Estevez; Adelina Riarte; J Estevez
Journal:  Mem Inst Oswaldo Cruz       Date:  2008-02       Impact factor: 2.743

3.  Three new sensitive and specific heat-shock protein 70 PCRs for global Leishmania species identification.

Authors:  A M Montalvo; J Fraga; I Maes; J-C Dujardin; G Van der Auwera
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-15       Impact factor: 3.267

4.  Effect of insecticide-impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matched-cluster randomised trial.

Authors:  A S Mazloumi Gavgani; M H Hodjati; H Mohite; C R Davies
Journal:  Lancet       Date:  2002-08-03       Impact factor: 79.321

5.  [Distribution of vectors of visceral leishmaniasis in the Province of Corrientes, 2008].

Authors:  Oscar D Salomón; Ladys K Ramos; María Gabriela Quintana; Soraya A Acardi; María Soledad Santini; Adolfo Schneider
Journal:  Medicina (B Aires)       Date:  2009       Impact factor: 0.653

6.  Leishmania infantum: lack of parasite resistance to amphotericin B in a clinically resistant visceral leishmaniasis.

Authors:  R Durand; M Paul; F Pratlong; D Rivollet; M L Dubreuil-Lemaire; R Houin; A Astier; M Deniau
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

7.  Parasitological diagnosis of canine visceral leishmaniasis: is intact skin a good target?

Authors:  M F Madeira; F B Figueiredo; A G S Pinto; L D Nascimento; M Furtado; E Mouta-Confort; C C de Paula; A Bogio; M C A Gomes; A M S Bessa; S R L Passos
Journal:  Res Vet Sci       Date:  2009-04-11       Impact factor: 2.534

8.  An essential type I nitroreductase from Leishmania major can be used to activate leishmanicidal prodrugs.

Authors:  Andrew A Voak; Vithurshaa Gobalakrishnapillai; Karin Seifert; Edina Balczo; Longqin Hu; Belinda S Hall; Shane R Wilkinson
Journal:  J Biol Chem       Date:  2013-08-14       Impact factor: 5.157

9.  Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning.

Authors:  Marcel Kaiser; Pascal Mäser; Leela Pavan Tadoori; Jean-Robert Ioset; Reto Brun
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

10.  Activation of Bicyclic Nitro-drugs by a Novel Nitroreductase (NTR2) in Leishmania.

Authors:  Susan Wyllie; Adam J Roberts; Suzanne Norval; Stephen Patterson; Bernardo J Foth; Matthew Berriman; Kevin D Read; Alan H Fairlamb
Journal:  PLoS Pathog       Date:  2016-11-03       Impact factor: 6.823

View more
  1 in total

1.  Amphotericin B resistance in Leishmania mexicana: Alterations to sterol metabolism and oxidative stress response.

Authors:  Edubiel A Alpizar-Sosa; Nur Raihana Binti Ithnin; Wenbin Wei; Andrew W Pountain; Stefan K Weidt; Anne M Donachie; Ryan Ritchie; Emily A Dickie; Richard J S Burchmore; Paul W Denny; Michael P Barrett
Journal:  PLoS Negl Trop Dis       Date:  2022-09-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.